Update on the impact of covid-19 on Vitrolife´s sales
Vitrolife estimates that sales in the second quarter will amount to about 40-50% of the corresponding period last year in local currency and that sales recovery will continue during the rest of the year.In connection with the interim report for January - March 2020, Vitrolife announced a large reduction in inflow of orders due to covid-19 during the beginning of the second quarter. Sales during the first weeks of April amounted to approximately one third of the corresponding period last year and the company then informed that the second quarter is expected to be very weak. Since the